Skip to main content
. 2023 Nov 13;4:1269758. doi: 10.3389/fcdhc.2023.1269758

Figure 1.

Figure 1

Median days of graft function considering positivity, negativity, or seroconvertion for GAD65/IA2 antibodies (n=47); Persistently positive = positivity for 1 or 2 autoantibodies. *P < 0.05 is noted between subjects persistently positive and subjects persistently negative.